The firm, founded in 2015, is an international venture capital firm that focuses solely on the advanced therapies sector. Their objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with a focus on biologics, gene and cell therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have a unique understanding of the criteria that define a successful investment opportunity in this space.